CASE pres Flashcards
You have measured the BPE- what is this? Discuss the results and how it influences your treatment of the Patient?
The BPE score indicates the level of examination & provide basic guidance on TX.
My patient has BPE 4 in all sextants- This means pockets >5.5mm present in all sextants. As well as bleeding on probing/calculus and plaque retentive factors.
Because we had BPEs of 4s we complete a 6 point pocket chart pre and post treatment as per the BSP & SDCEP Guidelines .
Discuss your 6 point pocket chart results?
Generalised loss of attachment (consistent with radiographs)
Generalised bleeding (Patient a smoker- reduces gingival bleeding)
No furcation involvement/ mobility of teeth.
Largest loss of attachment- 12mm DL to 44.
Largest pocket- 9mm DB to 46.
Why did you select OPT radiography and why?
The OPT was selected to see the patient’s bone levels.
This was selected over full mouth periapicals as we would need at least 7 more PA (1-8microsv per radiograph) compared to one OPT (4-30Mmicrosv)
These radiation dosages were are according to the international atomic energy agency.
What is your periodontal diagnosis and explain why you have selected it.
Generalised Stage 4 Grade C periodontitis, currently unstable with risk factor of smoking.
Generalised- >30% bone loss
Unstable- pockets > 4mm with BoP
Periodontitis- inflammation of Soft and hard tissues.
Stage IIII- Greatest bone loss apical third of the root (46 distal)
Grade C- 70%/age = 2.4 which is >1 so rapid progression.
Risk factors- patient smoked 10 a day for 13 years so 6.5 pack years.
Why is smoking a risk factor for periodontal disease
Smoking alters the balance present in the biofilm of the mouth triggering an immune system attack.
Increased production of inflammatory mediating cytokines- causing tissue breakdown.
There is reduced gingival blood flow- signs & symptoms of gingivitis are supressed.
Impaired white cell function causing impaired wound healing.
What are the modified plaque and bleeding scores and when do you complete them?
These are scores graded at each appointment using Ramfjord’s 6 teeth (16 21 24 36 41 44)- This pt doesn’t have all of ramfjord’s teeth- we used the 38 instead.
Used to monitor patient engagement.
Plaque score- 2(visible) 1(on probe) 0 (no plaque)- measured buccal/lingual/interproximal. out of 36.
Bleeding score- 1(Bleeding) 0(no bleeding)- measured buccal/ lingual/mesial/ distal out of 24.
For patient enagement- we want a Plaque score <20%. Bleeding score <30% or >50% improvement.
Your treatment plan includes a 3 month evaluation. Why is that?
3 months gives enough time for healing and decreased pocket depths for:
Oedema to reduce (causing gingival recession)
Increased clinical attachment due to the formation of the junctional epithelium. This increases tissue tone & causes resistance to probing.
What are we looking for at the 3 month patient evaluation?
SDCEP- pockets <4mm. Plaque score <15%. Bleeding score <10%
BSP-
Stable if <=4mm pockets (no BoP at any 4mm pockets) and <10% BOP
In remission if <=4mm pockets (no BoP at any 4mm pockets) and >10% BoP
Unstable if >=4mm pockets with BoP
What are the different results we can see at the Re-evaluation of the patient’s periodontal disease?
According to the BSP guidelines:
**Stable periodontitis **
* <=4mm pockets with no BOP at 4mm.
* BoP <10%
Periodontitis in remission
* <=4mm pockets with no BOP at 4mm.
* BoP >10%
**Unstable periodontitis. **
* >4mm pockets with BoP
What is the next part of the treatment plan if the patient returns for the 3 month evaluation and has not achieved the SDCEP or BSP stablility?
Reinforcing OHI/ risk factor control/ behaviour change.
Targeted PMPR of the unresponding pockets and re-evaluate.(4-5mm)
Any deep pockets >6mm refer for pocket management or regenerative therapy.
Hypothetically the patient’s periodontal treatment was successful what does the supportive phase consist of and how do we determine the appointment interval?
Reinforce OH/ risk factor control/ behaviour change
Targeted PMPR if the patient returns with any sites with subgingival pockets/ BoP >=4mm.
Only supragingival on sites <4mm without calculus.
According to the BSP
Patients in remission should be recalled every 3 months
Stable patients should be recalled every 6 months.
Consider- evidence based adjunctive effacious toothpaste/ mouthwash to control the gingival inflammation
Discuss the patient’s risk of Oral cancer?
3/4 of head and neck cancers are due to cigarette use and alcohol .
Normal risk 2.5 per 100,000
Pt 5x more at risk (as they smoke and drink)
How does smoking affect a patient’s oral health
Smoker’s keratosis
Leukoplakia
Chronic hyperplastic candidasis (promotes candida adhesion)
Lumps (that could be cancerous)
It alters the components in saliva (leading to a drier mouth)
Oral cancer- Cigarette smoke contains carcinogenic chemicals
Increased risk of periodontal disease
Failed dental treatments
Staining of teeth/dental restorations/ dentures
Halitosis
Black hairy tongue (due to the nictoine staining the papillae of the tongue)
What is smoker’s keratosis
Trauma found where the tobacco is held from thermal gases which causes a white and brown staining on the patient’s palate.
This is due to a thicker keratin layer (white colour) & melanin overproduction.
Malignancy is not common but can be seen.
What is leukoplakia and how is it related to smoking?
Leukoplakia is an undiagnosed white patch that cannot be scraped off.
It is a potentially malignant lesion that smokers are x6 more likely to have.
Your patient attends with a leukoplakia, what do you do?
A Leukoplakia is a pottentially malignant lesion- so we biopsy this to exclude carcinoma and assess for candida.
How does chronic hyperplastic candidosis cause damage?
- Adherence to host cells
- Hydrolytic enzymes
- Candida hyphae invade deeper causing tissue damage & so we can observe epithelial dysplasia (increased malignancy risk)
Why are smokers at increased risk of chronic hyperplastic candiosis?
Smoking promotes increased keratinisation in the oral epithelium & smoke constituents increase fungal virulence (ability to cause harm )
What is chronic hyperplastic candiosis?
A candidal infection associated with smoking.
This cannot be scraped off.
We biopsy leukoplakia to test for this.
It is pre-malignant.
What are some clinical predictors of oral cancer malignancy?
Age (older >younger)
Gender (female > male)
Site (buccal mucosa low risk. Floor of mouth & tongue- high risk)
Clinical- if it is non homogeneous- verrucous/ ulcerated/leukoerythroplakia.
You have requested histopathology of your biopsied site. What are we looking for?
Changes in the tissue architecture/ cytology.
Can be:
Basal hyperplasia/ Mild/ Moderate/ Severe/ Carcinoma in situ.
What is the most common type of oral cancer ?
Squamous cell carcinoma
-Verrucous (outward growing)
-Basaloid (associated with HPV)
-Spindle cell (aggressive)
Tell us about the patient’s smoking habits
He used to smoke 10 cigarettes a day for the past 13 years.
Started when he was 16.
He is currently using a vape to help him quit. Positive- not smoking tobacco. Negative- we don’t know the long term implications.
List the 7 red flags for oral cancer.
- Ulcer persisting >2 weeks
- Rolled borders with necrotic centre
- Speckled- red and white appearance.
- Cervical lymphadenopathy (enlarged >1cm/ firm/ fixed tethered/ cannot move/ not tender)
- Worsening pain (neuropathic/ paraesthesia/ dysaestheisa)
- Weight loss (i.e. local or systemic effects)